BAM Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.98M Buy
1,708
+194
+13% +$229K 1.07% 21
2026
Q2
$1.82M Sell
1,514
-55
-4% -$56.2K 1.14% 20
2026
Q1
$1.44M Buy
1,569
+357
+29% +$362K 1.08% 21
2025
Q4
$1.3M Sell
1,212
-212
-15% -$203K 0.94% 22
2025
Q3
$1.09M Buy
+1,424
New +$1.06M 0.84% 25

Other funds holding LLY

BAM Wealth Management's LLY Position: Q3 2026 in Review

BAM Wealth Management increased its Eli Lilly (LLY) stake by 13% in Q3 2026, buying an estimated $229K and bringing the position to 1,708 shares worth $1.98M. The position accounts for 1.07% of the portfolio, ranked #21.

BAM Wealth Management first reported a position in LLY in Q3 2025 and has held it in 5 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BAM Wealth Management held 1,708 shares of Eli Lilly worth $1.98M as of Q3 2026.
  • BAM Wealth Management bought 194 Eli Lilly shares in Q3 2026, an estimated $229K.
  • Eli Lilly made up 1.07% of BAM Wealth Management's portfolio in Q3 2026, its #21 holding.
  • BAM Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 5 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BAM Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.